This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stone, C. K. Articles by Rumsey, W. L. Search for Related Content PubMed PubMed Citation Articles by Stone, C. K. Articles by Rumsey, W. L.

(Circulation. 1995;92:1246-1253.)
© 1995 American Heart Association, Inc.

Articles

Myocardial Kinetics of a Putative Hypoxic Tissue Marker, ^99mTc-Labeled Nitroimidazole (BMS-181321), After Regional Ischemia and Reperfusion

Presented in part at the 40th Annual Meeting of the Society of Nuclear Medicine, Toronto, June 8-11, 1993.

Charles K. Stone, MD; Timothy Mulnix, MS; Robert J. Nickles, PhD; Britta Renstrom, PhD; Stephen H. Nellis, PhD; A. James Liedtke, MD; Adrian D. Nunn, PhD; Bruce L. Kuczynski, BS; William L. Rumsey, PhD

From the Cardiovascular Research Laboratory, the Departments of Medicine (Cardiology), Medical Physics, and Radiology (Nuclear Medicine), University of Wisconsin at Madison, and Bracco Research USA (A.D.N., B.L.K., W.L.R.), Princeton, NJ.

Correspondence to Charles K. Stone, MD, H6/317, Cardiology Section, Clinical Sciences Center, University of Wisconsin–Madison, 600 Highland Ave, Madison, WI 53792.

Background A new nitroimidazole complex, ^99mTc-propylene amine oxime-1,2-nitroimidazole (BMS-181321), has been developed to allow the positive imaging of hypoxic myocardium by standard gamma camera techniques.

Methods and Results To determine the myocardial kinetics of BMS-181321 during myocardial ischemia and reperfusion, seven open-chest swine were prepared according to a model of extracorporeal coronary perfusion in which left ventricular wall thickening (percent end-diastolic thickness) and substrate use in the left anterior descending (LAD) region ([¹⁴C]palmitate and [³H]glucose infusions) were determined. Measurements were obtained at baseline, during 40 minutes of ischemia produced by reducing flow in the LAD distribution by 60%, and during 70 minutes of reperfusion. Three aerobic control hearts were also studied in which LAD blood flow was not reduced. Regional coronary circulation was further assessed in all hearts by use of radiolabeled microspheres injected during ischemia. BMS-181321 (20 to 30 mCi) was injected after 30 minutes of ischemia, and its myocardial uptake was assessed by dynamic planar gamma imaging. Ischemia was associated with declines in fatty acid metabolism (15±11 µmol · h^-1 · g dry wt^-1, mean±SEM), systolic wall thickening (20±6%), and myocardial oxygen consumption (3±1 mL · min^-1 · 100 g^-1) and an increase in exogenous glucose utilization (75±13 µmol · h^-1 · g dry wt^-1). Systolic wall thickening recovered by only 8±3% with reperfusion. Initial distribution of BMS-181321 in the aerobic hearts appeared homogeneous. Washout from the ischemic and reperfused LAD bed was slower than the aerobically perfused LAD bed in the control group (t_1/2=136±1 versus 80±1 minutes, P<.05), allowing visualization of the LAD region during reperfusion. Tissue activity of BMS-181321 was inversely related to LAD blood flow during ischemia (r=-.68±.05), and the ratio of BMS-181321 in the LAD region versus normal myocardium was 1.7±0.2. Control swine lacked regional deposition of the tracer in the normally perfused LAD distribution.

Conclusions Thus, acute regional ischemia in these studies was visualized as an increase in retention of BMS-181321, suggesting its applicability in the imaging of clinical conditions of myocardial hypoperfusion.

Key Words: technetium • isotopes • nitroimidazole • myocardium • ischemia

This article has been cited by other articles:

				L. Kalinowski, L. W. Dobrucki, D. F. Meoli, D. P. Dione, M. M. Sadeghi, J. A. Madri, and A. J. Sinusas Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction J Appl Physiol, May 1, 2008; 104(5): 1504 - 1512. [Abstract] [Full Text] [PDF]

				E. Lu, W. R. Wagner, U. Schellenberger, J. A. Abraham, A. L. Klibanov, S. R. Woulfe, M. M. Csikari, D. Fischer, G. F. Schreiner, G. H. Brandenburger, et al. Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor: Approach to Identification of Ischemic Tissue Circulation, July 8, 2003; 108(1): 97 - 103. [Abstract] [Full Text] [PDF]

				R. D. Okada, G. Johnson III, K. N. Nguyen, Z. Liu, B. Edwards, C. M. Archer, T. L. North, A. C. King, and J. D. Kelly 99mTc-HL91 : "Hot Spot" Detection of Ischemic Myocardium In Vivo by Gamma Camera Imaging Circulation, June 30, 1998; 97(25): 2557 - 2566. [Abstract] [Full Text] [PDF]

				Y. Watanabe, H. Kusuoka, K. Fukuchi, T. Fujiwara, and T. Nishimura Contribution of hypoxia to the development of cardiomyopathy in hamsters Cardiovasc Res, August 1, 1997; 35(2): 217 - 222. [Abstract] [Full Text] [PDF]

				R. D. Okada, G. Johnson III, K. N. Nguyen, B. Edwards, C. M. Archer, and J. D. Kelly 99mTc-HL91 : Effects of Low Flow and Hypoxia on a New Ischemia-Avid Myocardial Imaging Agent Circulation, April 1, 1997; 95(7): 1892 - 1899. [Abstract] [Full Text]